Skip to Content

553 Results Found

  • Review
  • Open Access
19 Citations
4,736 Views
17 Pages

Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC

  • Sara Carpi,
  • Simona Daniele,
  • Jacqueline Fátima Martins de Almeida and
  • Daniela Gabbia

14 November 2024

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease (NAFLD), is a growing health concern worldwide, affecting more than 1 billion adults. It may progress to metabolic dysfunction-assoc...

  • Review
  • Open Access
62 Citations
7,972 Views
23 Pages

MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges?

  • Han Yang,
  • Yufang Liu,
  • Longqing Chen,
  • Juanjuan Zhao,
  • Mengmeng Guo,
  • Xu Zhao,
  • Zhenke Wen,
  • Zhixu He,
  • Chao Chen and
  • Lin Xu

Lung cancer is a commonly diagnosed cancer and the leading cause of cancer-related deaths, posing a serious health risk. Despite new advances in immune checkpoint and targeted therapies in recent years, the prognosis for lung cancer patients, especia...

  • Review
  • Open Access
534 Citations
21,892 Views
18 Pages

MicroRNA-Based Diagnosis and Therapy

  • Phuong T. B. Ho,
  • Ian M. Clark and
  • Linh T. T. Le

MicroRNAs (miRNAs) are a group of endogenous non-coding RNAs that regulate gene expression. Alteration in miRNA expression results in changes in the profile of genes involving a range of biological processes, contributing to numerous human disorders....

  • Review
  • Open Access
27 Citations
5,487 Views
30 Pages

10 June 2023

Prostate cancer (PCa) is the most frequently diagnosed cancer and the second leading cause of cancer deaths among American men. Complex genetic and epigenetic mechanisms are involved in the development and progression of PCa. MicroRNAs (miRNAs) are s...

  • Article
  • Open Access
166 Citations
13,445 Views
18 Pages

Bovine Milk-Derived Exosomes as a Drug Delivery Vehicle for miRNA-Based Therapy

  • Lorena del Pozo-Acebo,
  • M-C López de las Hazas,
  • Joao Tomé-Carneiro,
  • Paula Gil-Cabrerizo,
  • Rodrigo San-Cristobal,
  • Rebeca Busto,
  • Almudena García-Ruiz and
  • Alberto Dávalos

22 January 2021

MicroRNAs (miRNAs) are small non-coding RNAs with a known role as mediators of gene expression in crucial biological processes, which converts them into high potential contenders in the ongoing search for effective therapeutic strategies. However, ex...

  • Review
  • Open Access
71 Citations
10,839 Views
29 Pages

miRNA-Based Technologies in Cancer Therapy

  • Maria Pagoni,
  • Claudia Cava,
  • Diamantis C. Sideris,
  • Margaritis Avgeris,
  • Vassilios Zoumpourlis,
  • Ioannis Michalopoulos and
  • Nikolaos Drakoulis

9 November 2023

The discovery of therapeutic miRNAs is one of the most exciting challenges for pharmaceutical companies. Since the first miRNA was discovered in 1993, our knowledge of miRNA biology has grown considerably. Many studies have demonstrated that miRNA ex...

  • Review
  • Open Access
20 Citations
4,209 Views
14 Pages

miRNA Pathway Alteration in Response to Non-Coding RNA Delivery in Viral Vector-Based Gene Therapy

  • Darya A. Savenkova,
  • Aelita-Luiza A. Makarova,
  • Igor K. Shalik and
  • Dmitry V. Yudkin

29 November 2022

Gene therapy is widely used to treat incurable disorders and has become a routine procedure in clinical practice. Since viruses can exhibit specific tropisms, effectively penetrate the cell, and are easy to use, most gene therapy approaches are based...

  • Article
  • Open Access
7 Citations
2,736 Views
17 Pages

Combined Treatment of Cancer Cells Using Allyl Palladium Complexes Bearing Purine-Based NHC Ligands and Molecules Targeting MicroRNAs miR-221-3p and miR-222-3p: Synergistic Effects on Apoptosis

  • Chiara Tupini,
  • Matteo Zurlo,
  • Jessica Gasparello,
  • Irene Lodi,
  • Alessia Finotti,
  • Thomas Scattolin,
  • Fabiano Visentin,
  • Roberto Gambari and
  • Ilaria Lampronti

Combined treatments employing lower concentrations of different drugs are used and studied to develop new and more effective anticancer therapeutic approaches. The combination therapy could be of great interest in the controlling of cancer. Regarding...

  • Review
  • Open Access
8 Citations
3,759 Views
16 Pages

16 December 2021

Increasing evidence has demonstrated the functional roles of miRNAs and lncRNAs in lymphoma onset and progression, either by acting as tumor-promoting ncRNAs or as tumor suppressors, emphasizing their appeal as lymphoma therapeutics. In fact, their i...

  • Review
  • Open Access
49 Citations
5,040 Views
22 Pages

6 September 2021

Prostate cancer (PCa) is one of the most prevalent cancer types in males and the consequences of its distant metastatic deposits are the leading cause of PCa mortality. Therefore, identifying the causes and molecular mechanisms of hematogenous metast...

  • Review
  • Open Access
1,708 Views
23 Pages

Nuclear Receptors in Bladder Cancer: Insights into miRNA-Mediated Regulation and Potential Therapeutic Implications

  • José Javier Flores-Estrada,
  • Adriana Jiménez,
  • Georgina Victoria-Acosta,
  • Enoc Mariano Cortés-Malagón,
  • María Guadalupe Ortiz-López,
  • María Elizbeth Alvarez-Sánchez,
  • Stephanie I. Nuñez-Olvera,
  • Yussel Fernando Pérez-Navarro,
  • Marcos Morales-Reyna and
  • Jonathan Puente-Rivera

Nuclear receptors (NRs) are ligand-activated transcription factors that regulate gene expression and are involved in diverse physiological and pathological processes, including carcinogenesis. In bladder cancer (BCa), dysregulation of NR signaling pa...

  • Review
  • Open Access
15 Citations
3,824 Views
15 Pages

MicroRNAs as a Potential New Preventive Approach in the Transition from Asymptomatic to Symptomatic Multiple Myeloma Disease

  • Vanessa Desantis,
  • Antonio Giovanni Solimando,
  • Ilaria Saltarella,
  • Antonio Sacco,
  • Viviana Giustini,
  • Marta Bento,
  • Aurelia Lamanuzzi,
  • Assunta Melaccio,
  • Maria Antonia Frassanito and
  • Aldo M. Roccaro
  • + 3 authors

21 July 2021

Multiple myeloma (MM) is a hematological malignancy characterised by proliferation of clonal plasma cells (PCs) within the bone marrow (BM). Myelomagenesis is a multi-step process which goes from an asymptomatic phase, defined as monoclonal gammopath...

  • Article
  • Open Access
34 Citations
5,311 Views
21 Pages

MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-Myc

  • Eleni Anastasiadou,
  • Elena Messina,
  • Tiziana Sanavia,
  • Lucia Mundo,
  • Federica Farinella,
  • Stefano Lazzi,
  • Francesca Megiorni,
  • Simona Ceccarelli,
  • Paola Pontecorvi and
  • Cinzia Marchese
  • + 7 authors

1 March 2021

Conventional/targeted chemotherapies and ionizing radiation (IR) are being used both as monotherapies and in combination for the treatment of epithelial ovarian cancer (EOC). Several studies show that these therapies might favor oncogenic signaling a...

  • Review
  • Open Access
65 Citations
9,220 Views
32 Pages

MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies

  • Hyun Ah Seo,
  • Sokviseth Moeng,
  • Seokmin Sim,
  • Hyo Jeong Kuh,
  • Soo Young Choi and
  • Jong Kook Park

20 December 2019

The susceptibility of cancer cells to different types of treatments can be restricted by intrinsic and acquired therapeutic resistance, leading to the failure of cancer regression and remission. To overcome this problem, a combination therapy has bee...

  • Review
  • Open Access
24 Citations
4,162 Views
22 Pages

Mechanisms Controlling MicroRNA Expression in Tumor

  • Shipeng Chen,
  • Ya Wang,
  • Dongmei Li,
  • Hui Wang,
  • Xu Zhao,
  • Jing Yang,
  • Longqing Chen,
  • Mengmeng Guo,
  • Juanjuan Zhao and
  • Lin Xu
  • + 3 authors

13 September 2022

MicroRNAs (miRNAs) are widely present in many organisms and regulate the expression of genes in various biological processes such as cell differentiation, metabolism, and development. Numerous studies have shown that miRNAs are abnormally expressed i...

  • Review
  • Open Access
276 Citations
32,822 Views
41 Pages

25 January 2024

The discovery of the link between microRNAs (miRNAs) and a myriad of human diseases, particularly various cancer types, has generated significant interest in exploring their potential as a novel class of drugs. This has led to substantial investments...

  • Review
  • Open Access
19 Citations
4,338 Views
12 Pages

16 November 2021

MiRNA-regulated processes are pivotal in cardiovascular homeostasis and disease. These short non-coding RNAs have ideal properties that could be utilized as potential biomarkers; moreover, their functions as post-transcriptional regulators of mRNA ma...

  • Review
  • Open Access
16 Citations
6,675 Views
24 Pages

MicroRNAs in Prion Diseases—From Molecular Mechanisms to Insights in Translational Medicine

  • Danyel Fernandes Contiliani,
  • Yasmin de Araújo Ribeiro,
  • Vitor Nolasco de Moraes and
  • Tiago Campos Pereira

29 June 2021

MicroRNAs (miRNAs) are small non-coding RNA molecules able to post-transcriptionally regulate gene expression via base-pairing with partially complementary sequences of target transcripts. Prion diseases comprise a singular group of neurodegenerative...

  • Review
  • Open Access
17 Citations
3,576 Views
12 Pages

1 December 2020

The functional involvement of microRNAs in human neoplasia has raised in the last years an increasing interest in the scientific community toward the potential application in clinics as therapeutic tools. Indeed, the possibility to modulate their exp...

  • Review
  • Open Access
68 Citations
10,525 Views
32 Pages

MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases

  • T. P. Nhung Nguyen,
  • Mandeep Kumar,
  • Ernesto Fedele,
  • Giambattista Bonanno and
  • Tiziana Bonifacino

MicroRNAs (miRNAs) are essential post-transcriptional gene regulators involved in various neuronal and non-neuronal cell functions and play a key role in pathological conditions. Numerous studies have demonstrated that miRNAs are dysregulated in majo...

  • Review
  • Open Access
4 Citations
2,148 Views
16 Pages

The Emerging Role of MicroRNAs in Nasal Inflammatory Diseases and Tumors: From Bench to Bedside

  • Antonella Loperfido,
  • Carlo Cavaliere,
  • Bruno Fionda,
  • Simonetta Masieri,
  • Gianluca Bellocchi,
  • Massimo Re and
  • Marco Tomasetti

28 February 2025

Background/Objectives: MicroRNAs (miRNAs) play a crucial role in regulating immune responses and have been implicated in the pathogenesis of various nasal diseases, including chronic rhinosinusitis (CRS), allergic rhinitis (AR), and sinonasal tumors....

  • Review
  • Open Access
14 Citations
6,169 Views
23 Pages

Nonalcoholic fatty liver disease (NAFLD) has emerged as a global health problem that affects people even at young ages due to unhealthy lifestyles. Without intervention, NAFLD will develop into nonalcoholic steatohepatitis (NASH) and eventually liver...

  • Review
  • Open Access
13 Citations
3,484 Views
20 Pages

15 December 2023

The alarmingly low five-year survival rate for pancreatic cancer presents a global health challenge, contributing to about 7% of all cancer-related deaths. Late-stage diagnosis and high heterogeneity are the biggest hurdles in treating pancreatic can...

  • Review
  • Open Access
40 Citations
7,050 Views
23 Pages

Targeting microRNAs as a Therapeutic Strategy to Reduce Oxidative Stress in Diabetes

  • Giuseppina Emanuela Grieco,
  • Noemi Brusco,
  • Giada Licata,
  • Laura Nigi,
  • Caterina Formichi,
  • Francesco Dotta and
  • Guido Sebastiani

17 December 2019

Diabetes mellitus is a group of heterogeneous metabolic disorders characterized by chronic hyperglycaemia as a consequence of pancreatic β cell loss and/or dysfunction, also caused by oxidative stress. The molecular mechanisms involved inβ...

  • Review
  • Open Access
86 Citations
9,112 Views
36 Pages

The use of non-coding RNAs (ncRNAs) as drug targets is being researched due to their discovery and their role in disease. Targeting ncRNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), is an attractive approach for treating variou...

  • Review
  • Open Access
44 Citations
9,158 Views
27 Pages

Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases

  • Shih-Chun Yang,
  • Ahmed Alalaiwe,
  • Zih-Chan Lin,
  • Yu-Chih Lin,
  • Ibrahim A. Aljuffali and
  • Jia-You Fang

3 August 2022

Skin inflammation occurs due to immune dysregulation because of internal disorders, infections, and allergic reactions. The inflammation of the skin is a major sign of chronic autoimmune inflammatory diseases, such as psoriasis, atopic dermatitis (AD...

  • Article
  • Open Access
4 Citations
9,174 Views
11 Pages

A Versatile Tool for Stable Inhibition of microRNA Activity

  • Paride Pelucchi,
  • Valeria Tria,
  • Valentina Martino,
  • Davood Sabour,
  • Giovanni Bertalot,
  • Stefano Molgora,
  • Mira Palizban,
  • Martin Götte,
  • Ileana Zucchi and
  • Rolland A. Reinbold

28 June 2013

MicroRNAs (miRNAs) are a class of small RNAs (18–22 nt) that post transcriptionally regulate gene expression by binding to complementary sequences on target mRNAs, resulting in translational repression or target degradation and gene silencing. As abe...

  • Review
  • Open Access
301 Citations
14,637 Views
29 Pages

miRNA: A Promising Therapeutic Target in Cancer

  • Amrutha Menon,
  • Noraini Abd-Aziz,
  • Kanwal Khalid,
  • Chit Laa Poh and
  • Rakesh Naidu

29 September 2022

microRNAs are small non-coding RNAs that regulate several genes post-transcriptionally by complementarity pairing. Since discovery, they have been reported to be involved in a variety of biological functions and pathologies including cancer. In cance...

  • Review
  • Open Access
9 Citations
3,321 Views
28 Pages

Therapeutic Applications of Poly-miRNAs and miRNA Sponges

  • Cynthia Avendaño-Portugal,
  • Mariela Montaño-Samaniego,
  • Raquel Guttman-Bazbaz,
  • Diana M. Bravo-Estupiñan and
  • Miguel Ibáñez-Hernández

MicroRNAs (miRNAs) are small, non-coding RNA molecules that play crucial roles in regulating gene expression, and their dysregulation is implicated in various human diseases. Over the years, several research groups have identified miRNAs as promising...

  • Systematic Review
  • Open Access
3,435 Views
18 Pages

Pre-Clinical Studies of MicroRNA-Based Therapies for Sepsis: A Scoping Review

  • Amin M. Ektesabi,
  • Julia Simone,
  • Chirag Vaswani,
  • Greaton W. Tan,
  • Yanbo Wang,
  • Jacqueline L. Pavelick,
  • Xiao Wu,
  • Janice Tai,
  • Sahil Gupta and
  • Claudia C. dos Santos
  • + 1 author

29 January 2024

Background: Sepsis is a severe and life-threatening condition triggered by a dysregulated response to infection, leading to organ failure and, often, death. The syndrome is expensive to treat, with survivors frequently experiencing reduced quality of...

  • Review
  • Open Access
71 Citations
5,503 Views
20 Pages

Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs

  • Patrizia Leone,
  • Alessio Buonavoglia,
  • Rossella Fasano,
  • Antonio Giovanni Solimando,
  • Valli De Re,
  • Sebastiano Cicco,
  • Angelo Vacca and
  • Vito Racanelli

20 November 2019

One of the hallmarks of cancer is angiogenesis, a series of events leading to the formation of the abnormal vascular network required for tumor growth, development, progression, and metastasis. MicroRNAs (miRNAs) are short, single-stranded, non-codin...

  • Review
  • Open Access
26 Citations
10,702 Views
41 Pages

MicroRNAs (miRNAs) are small non-coding RNAs that can post-transcriptionally regulate the genes involved in critical cellular processes. The aberrant expressions of oncogenic or tumor suppressor miRNAs have been associated with cancer progression and...

  • Review
  • Open Access
8 Citations
4,540 Views
18 Pages

LAT1 and ASCT2 Related microRNAs as Potential New Therapeutic Agents against Colorectal Cancer Progression

  • Francisca Dias,
  • Cristina Almeida,
  • Ana Luísa Teixeira,
  • Mariana Morais and
  • Rui Medeiros

The development and progression of colorectal cancer (CRC) have been associated with genetic and epigenetic alterations and more recently with changes in cell metabolism. Amino acid transporters are key players in tumor development, and it is describ...

  • Review
  • Open Access
4 Citations
4,383 Views
16 Pages

Retinopathy of Prematurity and MicroRNAs

  • Giuseppe Maria Albanese,
  • Giacomo Visioli,
  • Ludovico Alisi,
  • Marta Armentano,
  • Francesca Giovannetti,
  • Luca Lucchino,
  • Marco Marenco,
  • Paola Pontecorvi and
  • Magda Gharbiya

Retinopathy of Prematurity (ROP), a leading cause of blindness in preterm infants, arises from dysregulated angiogenesis and inflammation. Without timely intervention, ROP can progress to severe outcomes, including dense fibrovascular plaques and ret...

  • Review
  • Open Access
207 Citations
21,222 Views
18 Pages

miRNAs: Potential as Biomarkers and Therapeutic Targets for Cancer

  • Atonu Chakrabortty,
  • Daniel J. Patton,
  • Bruce F. Smith and
  • Payal Agarwal

29 June 2023

MicroRNAs (miRNAs) are single-stranded, non-coding RNA molecules that regulate gene expression post-transcriptionally by binding to messenger RNAs. miRNAs are important regulators of gene expression, and their dysregulation is implicated in many huma...

  • Review
  • Open Access
11 Citations
3,350 Views
13 Pages

MiRNA as a Potential Target for Multiple Myeloma Therapy–Current Knowledge and Perspectives

  • Aneta Szudy-Szczyrek,
  • Sean Ahern,
  • Janusz Krawczyk,
  • Michał Szczyrek and
  • Marek Hus

31 August 2022

Multiple myeloma (MM) is the second most common hematological malignancy. Despite the huge therapeutic progress thanks to the introduction of novel therapies, MM remains an incurable disease. Extensive research is currently ongoing to find new option...

  • Review
  • Open Access
18 Citations
4,603 Views
23 Pages

Tiny miRNAs Play a Big Role in the Treatment of Breast Cancer Metastasis

  • Andrea York Tiang Teo,
  • Xiaoqiang Xiang,
  • Minh TN Le,
  • Andrea Li-Ann Wong,
  • Qi Zeng,
  • Lingzhi Wang and
  • Boon-Cher Goh

18 January 2021

Distant organ metastases accounts for the majority of breast cancer deaths. Given the prevalence of breast cancer in women, it is imperative to understand the underlying mechanisms of its metastatic progression and identify potential targets for ther...

  • Review
  • Open Access
170 Citations
17,880 Views
28 Pages

MicroRNA Therapeutics in Cancer: Current Advances and Challenges

  • Soha Reda El Sayed,
  • Justine Cristante,
  • Laurent Guyon,
  • Josiane Denis,
  • Olivier Chabre and
  • Nadia Cherradi

29 May 2021

The discovery of microRNAs (miRNAs) in 1993 has challenged the dogma of gene expression regulation. MiRNAs affect most of cellular processes from metabolism, through cell proliferation and differentiation, to cell death. In cancer, deregulated miRNA...

  • Review
  • Open Access
12 Citations
3,725 Views
22 Pages

How MicroRNAs Command the Battle against Cancer

  • Hong Helena Wu,
  • Sarah Leng,
  • Consolato Sergi and
  • Roger Leng

MicroRNAs (miRNAs) are small RNA molecules that regulate more than 30% of genes in humans. Recent studies have revealed that miRNAs play a crucial role in tumorigenesis. Large sets of miRNAs in human tumors are under-expressed compared to normal tiss...

  • Review
  • Open Access
9 Citations
3,511 Views
19 Pages

Oxidative Stress Modulation by ncRNAs and Their Emerging Role as Therapeutic Targets in Atherosclerosis and Non-Alcoholic Fatty Liver Disease

  • Jorge Infante-Menéndez,
  • Paula González-López,
  • Raquel Huertas-Lárez,
  • Almudena Gómez-Hernández and
  • Óscar Escribano

24 January 2023

Atherosclerosis and non-alcoholic fatty liver disease (NAFLD) are pathologies related to ectopic fat accumulation, both of which are continuously increasing in prevalence. These threats are prompting researchers to develop effective therapies for the...

  • Review
  • Open Access
21 Citations
6,191 Views
14 Pages

Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens

  • Álvaro Mourenza,
  • Blanca Lorente-Torres,
  • Elena Durante,
  • Jesús Llano-Verdeja,
  • Jesús F. Aparicio,
  • Arsenio Fernández-López,
  • José A. Gil,
  • Luis M. Mateos and
  • Michal Letek

The development of RNA-based anti-infectives has gained interest with the successful application of mRNA-based vaccines. Small RNAs are molecules of RNA of <200 nucleotides in length that may control the expression of specific genes. Small RNAs in...

  • Review
  • Open Access
49 Citations
7,920 Views
22 Pages

28 January 2022

Within the past years, more and more attention has been devoted to the epigenetic dysregulation that provides an additional window for understanding the possible mechanisms involved in the pathogenesis of autoimmune rheumatic diseases. Rheumatoid art...

  • Review
  • Open Access
9 Citations
4,259 Views
25 Pages

Mimic miRNA and Anti-miRNA Activated Scaffolds as a Therapeutic Strategy to Promote Bone, Cartilage, and Skin Regeneration

  • Gabriella Guelfi,
  • Camilla Capaccia,
  • Polina Anipchenko,
  • Francesco Ciancabilla,
  • Oommen Podiyan Oommen,
  • Antonello Bufalari,
  • Massimo Zerani and
  • Margherita Maranesi

1 April 2024

MiRNA-based therapies represent an innovative and promising strategy applicable to various medical fields, such as tissue regeneration and the treatment of numerous diseases, including cancer, cardiovascular problems, and viral infections. MiRNAs, a...

  • Review
  • Open Access
43 Citations
7,587 Views
24 Pages

Exosomes as Natural Nanocarriers for RNA-Based Therapy and Prophylaxis

  • Andrey Gorshkov,
  • Lada Purvinsh,
  • Alexandra Brodskaia and
  • Andrey Vasin

2 February 2022

Exosomes are natural nanocontainers actively secreted by the body’s cells and transmitting molecular signals of various types to recipient cells. Cellular mechanisms of exosomes’ biogenesis involve specific sorting of RNA for incorporatio...

  • Review
  • Open Access
4 Citations
3,825 Views
25 Pages

microRNAs in Type 1 Diabetes: Roles, Pathological Mechanisms, and Therapeutic Potential

  • Hayeong Cho,
  • Se Eun Ha,
  • Rajan Singh,
  • David Kim and
  • Seungil Ro

Type 1 diabetes (T1D) is a chronic autoimmune disease characterized by the progressive destruction of pancreatic β-cells, leading to insulin deficiency. The primary drivers of β-cell destruction in T1D involve autoimmune-mediated processes...

  • Review
  • Open Access
11 Citations
9,943 Views
13 Pages

Targeting MicroRNA in Cancer Using Plant-Based Proanthocyanidins

  • Rishipal R. Bansode,
  • Janak R. Khatiwada,
  • Jack N. Losso and
  • Leonard L. Williams

Proanthocyanidins are oligomeric flavonoids found in plant sources, most notably in apples, cinnamon, grape skin and cocoa beans. They have been also found in substantial amounts in cranberry, black currant, green tea, black tea and peanut skins. The...

  • Review
  • Open Access
21 Citations
5,672 Views
26 Pages

Could MicroRNAs Be Useful Tools to Improve the Diagnosis and Treatment of Rare Gynecological Cancers? A Brief Overview

  • Riccardo Di Fiore,
  • Sherif Suleiman,
  • Francesca Pentimalli,
  • Sharon A. O’Toole,
  • John J. O’Leary,
  • Mark P. Ward,
  • Neil T. Conlon,
  • Maja Sabol,
  • Petar Ozretić and
  • Jean Calleja-Agius
  • + 4 authors

Gynecological cancers pose an important public health issue, with a high incidence among women of all ages. Gynecological cancers such as malignant germ-cell tumors, sex-cord-stromal tumors, uterine sarcomas and carcinosarcomas, gestational trophobla...

  • Review
  • Open Access
30 Citations
4,575 Views
25 Pages

The Roles of microRNAs in the Cardiovascular System

  • Francesco Nappi,
  • Sanjeet Singh Avtaar Singh,
  • Vikram Jitendra,
  • Almothana Alzamil and
  • Thibaut Schoell

19 September 2023

The discovery of miRNAs and their role in disease represent a significant breakthrough that has stimulated and propelled research on miRNAs as targets for diagnosis and therapy. Cardiovascular disease is an area where the restrictions of early diagno...

  • Review
  • Open Access
1 Citations
1,327 Views
19 Pages

MicroRNAs as Emerging Therapeutic Targets Modulating the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma

  • Roxana Daniela Brata,
  • Lavinia Marcut,
  • Alina Cristina Barb,
  • Alexia Manole,
  • Alexandru Ciolofan,
  • Cristina Stefania Dumitru,
  • Flavia Zara and
  • Raul Patrascu

6 November 2025

Head and neck squamous cell carcinoma (HNSCC) remains one of the most aggressive solid tumors, characterized by marked molecular heterogeneity and a complex tumor microenvironment (TME). Recent evidence highlights the pivotal role of microRNAs (miRNA...

  • Review
  • Open Access
47 Citations
7,604 Views
20 Pages

Clinical Potential of microRNA-7 in Cancer

  • Jessica L. Horsham,
  • Felicity C. Kalinowski,
  • Michael R. Epis,
  • Clarissa Ganda,
  • Rikki A. M. Brown and
  • Peter J. Leedman

25 August 2015

microRNAs (miRNAs) are a family of short, non-coding RNA molecules that drive a complex network of post-transcriptional gene regulation by enhancing target mRNA decay and/or inhibiting protein synthesis from mRNA transcripts. They regulate genes invo...

of 12